|
|
|
|
Home | Search | Advance Search | Browse | Online Submission | Documentation & FAQ | Team | Contact us |
|
| PolysacDB ID | 1073 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe | Escherichia coli O18:K1:H7 (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | N/A |
| BCSDB Structure | N/A |
| Proposed functions | N/A |
| Antigenic Nature used to produce antibodies | Whole cells |
| Carrier Name | Nil |
| Conjugation Method | Nil |
| Antibodies | Mab 14 |
| Antibody type and class | IgM |
| Assay System | ELISA, invitro opsonophagocytosis assay, immunoblotting, invivo protection studies |
| Cross-reactivity | This Mab cross-reacted with other 018 E. coli strains but were unreactive with heterologous 0 serotypes (e.g., 075 E. coli), E. coli J-5 Rc, Salmonella typhimurium Re rough mutants, or other gram-negative bacteria. |
| Proposed epitopes | The epitope was proposed to consist of the O-antigen |
| IEDB Epitope | N/A |
| Proposed Utility | N/A |
| Curator ID | AA + AS |
| Date of Curation | 22-01-2010 |
| References | PMC261046 |
| PolysacDB ID | 1074 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe | Escherichia coli O18:K1:H7 (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | N/A |
| BCSDB Structure | N/A |
| Proposed functions | N/A |
| Antigenic Nature used to produce antibodies | Whole cells |
| Carrier Name | Nil |
| Conjugation Method | Nil |
| Antibodies | Mab 19 |
| Antibody type and class | IgG3 |
| Assay System | ELISA, invitro opsonophagocytosis assay, immunoblotting, invivo protection studies |
| Cross-reactivity | This Mab cross-reacted with other 018 E. coli strains but were unreactive with heterologous 0 serotypes (e.g., 075 E. coli), E. coli J-5 Rc, Salmonella typhimurium Re rough mutants, or other gram-negative bacteria. |
| Proposed epitopes | The epitope was proposed to consist of the O-antigen |
| IEDB Epitope | N/A |
| Proposed Utility | This Mab had invitro opsonophagocytic activity and showed complete protection in invivo models |
| Curator ID | AA + AS |
| Date of Curation | 23-01-2010 |
| References | PMC261046 |
| PolysacDB ID | 1075 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe | Escherichia coli O18:K1:H7 (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | N/A |
| BCSDB Structure | N/A |
| Proposed functions | N/A |
| Antigenic Nature used to produce antibodies | Whole cells |
| Carrier Name | Nil |
| Conjugation Method | Nil |
| Antibodies | Mab 26 |
| Antibody type and class | IgG1 |
| Assay System | ELISA, invitro opsonophagocytosis assay, immunoblotting, invivo protection studies |
| Cross-reactivity | This Mab cross-reacted with other 018 E. coli strains but were unreactive with heterologous 0 serotypes (e.g., 075 E. coli), E. coli J-5 Rc, Salmonella typhimurium Re rough mutants, or other gram-negative bacteria. |
| Proposed epitopes | The epitope was proposed to consist of the O-antigen |
| IEDB Epitope | N/A |
| Proposed Utility | This Mab had invitro opsonophagocytic activity and showed complete protection in invivo models |
| Curator ID | AA + AS |
| Date of Curation | 23-01-2010 |
| References | PMC261046 |
| PolysacDB ID | 1076 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe | Escherichia coli O18:K1:H7 (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | N/A |
| BCSDB Structure | N/A |
| Proposed functions | N/A |
| Antigenic Nature used to produce antibodies | Whole cells |
| Carrier Name | Nil |
| Conjugation Method | Nil |
| Antibodies | Mab 35 |
| Antibody type and class | IgM |
| Assay System | ELISA, invitro opsonophagocytosis assay, immunoblotting, invivo protection studies |
| Cross-reactivity | This Mab cross-reacted with other 018 E. coli strains but were unreactive with heterologous 0 serotypes (e.g., 075 E. coli), E. coli J-5 Rc, Salmonella typhimurium Re rough mutants, or other gram-negative bacteria. |
| Proposed epitopes | The epitope was proposed to consist of the O-antigen |
| IEDB Epitope | N/A |
| Proposed Utility | This Mab showed partial protection in invivo models |
| Curator ID | AA + AS |
| Date of Curation | 23-01-2010 |
| References | PMC261046 |
| PolysacDB ID | 1077 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe | Escherichia coli O18:K1:H7 (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | N/A |
| BCSDB Structure | N/A |
| Proposed functions | N/A |
| Antigenic Nature used to produce antibodies | Whole cells |
| Carrier Name | Nil |
| Conjugation Method | Nil |
| Antibodies | Mab 39 |
| Antibody type and class | IgM |
| Assay System | ELISA, invitro opsonophagocytosis assay, immunoblotting, invivo protection studies |
| Cross-reactivity | This Mab cross-reacted with other 018 E. coli strains but were unreactive with heterologous 0 serotypes (e.g., 075 E. coli), E. coli J-5 Rc, Salmonella typhimurium Re rough mutants, or other gram-negative bacteria. |
| Proposed epitopes | The epitope was proposed to consist of the O-antigen |
| IEDB Epitope | N/A |
| Proposed Utility | N/A |
| Curator ID | AA + AS |
| Date of Curation | 23-01-2010 |
| References | PMC261046 |
| PolysacDB ID | 1078 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe | Escherichia coli O18:K1:H7 (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | N/A |
| BCSDB Structure | N/A |
| Proposed functions | N/A |
| Antigenic Nature used to produce antibodies | Whole cells |
| Carrier Name | Nil |
| Conjugation Method | Nil |
| Antibodies | Mab 109 |
| Antibody type and class | IgM |
| Assay System | ELISA, invitro opsonophagocytosis assay, immunoblotting, invivo protection studies |
| Cross-reactivity | This Mab cross-reacted with other 018 E. coli strains but were unreactive with heterologous 0 serotypes (e.g., 075 E. coli), E. coli J-5 Rc, Salmonella typhimurium Re rough mutants, or other gram-negative bacteria. |
| Proposed epitopes | The epitope was proposed to consist of the O-antigen |
| IEDB Epitope | N/A |
| Proposed Utility | This Mab showed partial protection in invivo models |
| Curator ID | AA + AS |
| Date of Curation | 24-01-2010 |
| References | PMC261046 |
| PolysacDB ID | 1079 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe | Escherichia coli O18:K1:H7 (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | N/A |
| BCSDB Structure | N/A |
| Proposed functions | N/A |
| Antigenic Nature used to produce antibodies | Whole cells |
| Carrier Name | Nil |
| Conjugation Method | Nil |
| Antibodies | Mab 141 |
| Antibody type and class | IgM |
| Assay System | ELISA, invitro opsonophagocytosis assay, immunoblotting, invivo protection studies |
| Cross-reactivity | This Mab cross-reacted with other 018 E. coli strains but were unreactive with heterologous 0 serotypes (e.g., 075 E. coli), E. coli J-5 Rc, Salmonella typhimurium Re rough mutants, or other gram-negative bacteria. |
| Proposed epitopes | The epitope was proposed to consist of the O-antigen |
| IEDB Epitope | N/A |
| Proposed Utility | N/A |
| Curator ID | AA + AS |
| Date of Curation | 24-01-2010 |
| References | PMC261046 |
|
Bioinformatics Centre, Institute of Microbial Technology, Sec - 39A, Chandigarh, India - 160036 |